id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0446-0016,FDA,FDA-2003-N-0446,GCF-1,Other,SF-Separation of Functions,2003-10-24T04:00:00Z,2003,10,,,2008-04-12T01:09:51Z,,0,0,09000064804a2513
FDA-2003-N-0446-0014,FDA,FDA-2003-N-0446,HFV-1 to Buchanan Ingersoll,Other,LET-Letter,2003-10-07T04:00:00Z,2003,10,,,2008-04-12T01:09:51Z,,0,0,09000064804a2511
FDA-2003-N-0446-0015,FDA,FDA-2003-N-0446,FDA,Notice,NCR-Notice of Correction,2003-10-07T04:00:00Z,2003,10,2003-10-07T04:00:00Z,2003-11-07T04:59:59Z,2008-04-12T01:09:51Z,,0,0,09000064804a2512
FDA-2003-N-0446-0007,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:51Z,,0,0,09000064804a2502
FDA-2003-N-0446-0011,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:51Z,,0,0,09000064804a2506
FDA-2003-N-0446-0009,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:50Z,,0,0,09000064804a2504
FDA-2003-N-0446-0008,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:51Z,,0,0,09000064804a2503
FDA-2003-N-0446-0005,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:51Z,,0,0,09000064804a24ff
FDA-2003-N-0446-0002,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:51Z,,0,0,09000064804a24fc
FDA-2003-N-0446-0012,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:51Z,,0,0,09000064804a2507
FDA-2003-N-0446-0004,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:51Z,,0,0,09000064804a24fe
FDA-2003-N-0446-0001,FDA,FDA-2003-N-0446,FDA,Notice,NPR-Notice of Proposed Rule-Making,2003-08-14T04:00:00Z,2003,8,2003-08-08T04:00:00Z,2003-11-07T04:59:59Z,2008-04-12T01:09:50Z,,0,0,09000064804a24f6
FDA-2003-N-0446-0003,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:51Z,,0,0,09000064804a24fd
FDA-2003-N-0446-0013,FDA,FDA-2003-N-0446,FDA,Notice,NPH-Notice of Opportunity of Hearing,2003-08-14T04:00:00Z,2003,8,2003-08-07T04:00:00Z,2003-09-09T03:59:59Z,2008-04-12T01:09:51Z,,0,0,09000064804a2508
FDA-2003-N-0446-0010,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:51Z,,0,0,09000064804a2505
FDA-2003-N-0446-0006,FDA,FDA-2003-N-0446,BACKGROUND,Supporting & Related Material,BKG-Background Material,2003-08-14T04:00:00Z,2003,8,,,2008-04-12T01:09:51Z,,0,0,09000064804a2500